Microbiome Sampling in GI Disease With a Focus on Small Intestinal Microbial Assessment
Observational · No treatment assigned · Sites not listed yet · Stanford University
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Healthy, IBS - Irritable Bowel Syndrome and Inflammatory Bowel Diseases. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 to 100
- Any sex
- Healthy volunteers accepted
Some of the main requirements, copied from the record:
- Age >18years
- Patients seen at Stanford University Digestive Health Center who are scheduled for an upper endoscopy as part of their Standard Of Care
There are also 1 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 150 participants are expected to take part.
- Start date: 2024-01-01 (planned).
- Main results expected around 2026-01-01 (estimate from the record).
- No study sites are listed yet. Check the official record for contact details.
Main thing being measured
- Ability to isolate live bacteria from 95% of samples (1-4 years)
In the researchers’ words
GI disorders are influenced by the gut microbiome. To date, sampling of the small intestine in GI disorders has been limited.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Not yet recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Healthy; IBS - Irritable Bowel Syndrome; Inflammatory Bowel Diseases |
| Lead sponsor | Stanford University |
| Enrollment | 150 (estimated) |
| Start date | 2024-01-01 |
| Primary completion (est.) | 2026-01-01 |
| First posted | 2023-10-04 |
| Last updated | 2023-10-06 |
| Official title | Microbiome Sampling in GI Disease With a Focus on Small Intestinal Microbial Assessment |
| ClinicalTrials.gov ID | NCT06066866 |
Interventions
- endoscopic sampling of luminal fluid (Other)
We will collect luminal fluid via endoscopic sampling
Full eligibility criteria (from the record)
Inclusion Criteria: * Age >18years * Patients seen at Stanford University Digestive Health Center who are scheduled for an upper endoscopy as part of their Standard Of Care Exclusion Criteria: Children (under age 18years) Pregnant Women and Fetuses Neonates (0 - 28 days) Impaired Decision Making Capacity
Locations (0)
No sites listed yet. The official record has contact information.
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.